About
Technology
Issues
FAQ
Links
Official Page
Immunoproteasome inhibitor DPLG3 attenuates experimental colitis by restraining NF-κB activation
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.
